135 related articles for article (PubMed ID: 37837652)
1. A robust evaluation of 49 high-dose-rate prostate brachytherapy treatment plans including all major uncertainties.
Kennedy AC; Douglass MJJ; Santos AMC
J Appl Clin Med Phys; 2024 Feb; 25(2):e14182. PubMed ID: 37837652
[TBL] [Abstract][Full Text] [Related]
2. Being certain about uncertainties: a robust evaluation method for high-dose-rate prostate brachytherapy treatment plans including the combination of uncertainties.
Kennedy AC; Douglass MJJ; Santos AMC
Phys Eng Sci Med; 2023 Sep; 46(3):1115-1130. PubMed ID: 37249825
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric impact of a robust optimization approach to mitigate effects from rotational uncertainty in prostate intensity-modulated brachytherapy.
Morén B; Antaki M; Famulari G; Morcos M; Larsson T; Enger SA; Tedgren ÅC
Med Phys; 2023 Feb; 50(2):1029-1043. PubMed ID: 36478226
[TBL] [Abstract][Full Text] [Related]
4. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
[TBL] [Abstract][Full Text] [Related]
6. A comparison of treatment planning techniques for low-dose-rate (LDR) prostate brachytherapy.
Connolly D; Sands G; Winter H; Foley MJ; Kleefeld C
Brachytherapy; 2021; 20(2):410-419. PubMed ID: 33234407
[TBL] [Abstract][Full Text] [Related]
7. Fast mixed integer optimization (FMIO) for high dose rate brachytherapy.
Antaki M; L Deufel C; Enger SA
Phys Med Biol; 2020 Dec; 65(21):215005. PubMed ID: 33283763
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous needle catheter selection and dwell time optimization for preplanning of high-dose-rate brachytherapy of prostate cancer.
Wang C; Gonzalez Y; Shen C; Hrycushko B; Jia X
Phys Med Biol; 2021 Mar; 66(5):055028. PubMed ID: 33264753
[TBL] [Abstract][Full Text] [Related]
9. Catheter position prediction using deep-learning-based multi-atlas registration for high-dose rate prostate brachytherapy.
Lei Y; Wang T; Fu Y; Roper J; Jani AB; Liu T; Patel P; Yang X
Med Phys; 2021 Nov; 48(11):7261-7270. PubMed ID: 34480801
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.
Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Polgár C; Major T
Strahlenther Onkol; 2010 Jul; 186(7):388-95. PubMed ID: 20582396
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of robust optimization against geometric uncertainties in TomoHelical planning for prostate cancer.
Yagihashi T; Inoue K; Nagata H; Yamanaka M; Yamano A; Suzuki S; Yamakabe W; Sato N; Omura M; Inoue T
J Appl Clin Med Phys; 2023 Apr; 24(4):e13881. PubMed ID: 36576418
[TBL] [Abstract][Full Text] [Related]
12. Development of patient and catheter specific error thresholds for high dose rate prostate brachytherapy.
Koprivec D; Belanger C; Beaulieu L; Chatigny PY; Rosenfeld A; Cutajar D; Petasecca M; Howie A; Bucci J; Poder J
Med Phys; 2024 Mar; 51(3):2144-2154. PubMed ID: 38308854
[TBL] [Abstract][Full Text] [Related]
13. Development of a Monte Carlo based robustness calculation and evaluation tool.
Loebner HA; Volken W; Mueller S; Bertholet J; Mackeprang PH; Guyer G; Aebersold DM; Stampanoni MFM; Manser P; Fix MK
Med Phys; 2022 Jul; 49(7):4780-4793. PubMed ID: 35451087
[TBL] [Abstract][Full Text] [Related]
14. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of online adaptive HDR prostate brachytherapy: A novel treatment concept.
Koprivec D; Rosenfeld A; Cutajar D; Petasecca M; Howie A; Bucci J; Poder J
Brachytherapy; 2022; 21(6):943-955. PubMed ID: 36068155
[TBL] [Abstract][Full Text] [Related]
17. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
[TBL] [Abstract][Full Text] [Related]
19. HDR prostate brachytherapy plan robustness and its effect on in-vivo source tracking error thresholds: A multi-institutional study.
Poder J; Koprivec D; Dookie Y; Howie A; Cutajar D; Damato AL; Côté N; Petasecca M; Bucci J; Rosenfeld A
Med Phys; 2022 Jun; 49(6):3529-3537. PubMed ID: 35388456
[TBL] [Abstract][Full Text] [Related]
20. Dwell time modulation restrictions do not necessarily improve treatment plan quality for prostate HDR brachytherapy.
Balvert M; Gorissen BL; den Hertog D; Hoffmann AL
Phys Med Biol; 2015 Jan; 60(2):537-48. PubMed ID: 25549084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
